Want to join the conversation?
$LLY 2Q15 Call: In emerging markets, revenue declined 15% driven by negative FX of 12%. On a performance basis, emerging market sales declined 4% driven by lower sales in China and the negative effect of the Brazil Humulin tender LLY had last year. This quarter, Pharma revenue in China declined 16% driven by lower volume.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?